Pasqualucci D, Iacovoni A, Palmieri V, De Maria R, Iacoviello M, Battistoni I, Macera F, Olivotto I, Arbustini E, Mortara A (2022) Epidemiology of cardiomyopathies: essential context knowledge for a tailored clinical work-up. Eur J Prev Cardiol 29(8):1190–1199

PubMed  Google Scholar 

Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kuhl U, Maisch B, McKenna WJ et al (2008) Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29(2):270–276

Article  PubMed  Google Scholar 

Konno T, Chang S, Seidman JG, Seidman CE (2010) Genetics of hypertrophic cardiomyopathy. Curr Opin Cardiol 25(3):205–209

Article  PubMed  Google Scholar 

Garcia-Hernandez S, de la Higuera-Romero L, Ochoa JP, McKenna WJ (2024) Emerging themes in genetics of hypertrophic cardiomyopathy. Current status and clinical application. Can J Cardiol 2024:1

Google Scholar 

Heymans S, Lakdawala NK, Tschope C, Klingel K (2023) Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches. Lancet 402(10406):998–1011

Article  CAS  PubMed  Google Scholar 

Harper AR, Goel A, Grace C, Thomson KL, Petersen SE, Xu X, Waring A, Ormondroyd E, Kramer CM, Ho CY et al (2021) Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity. Nat Genet 53(2):135–142

Article  CAS  PubMed  PubMed Central  Google Scholar 

Japp AG, Gulati A, Cook SA, Cowie MR, Prasad SK (2016) The diagnosis and evaluation of dilated cardiomyopathy. J Am Coll Cardiol 67(25):2996–3010

Article  PubMed  Google Scholar 

Ikeda M, Ide T, Matsushima S, Ikeda S, Okabe K, Ishikita A, Tadokoro T, Sada M, Abe K, Sato M et al (2022) Immunomodulatory cell therapy using alphagalcer-pulsed dendritic cells ameliorates heart failure in a murine dilated cardiomyopathy model. Circ Heart Fail 15(12):e009366

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eleid MF, Konecny T, Orban M, Sengupta PP, Somers VK, Parish JM, Mookadam F, Brady PA, Sullivan BL, Khandheria BK et al (2009) High prevalence of abnormal nocturnal oximetry in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 54(19):1805–1809

Article  PubMed  Google Scholar 

Buckley BJR, Harrison SL, Gupta D, Fazio-Eynullayeva E, Underhill P, Lip GYH (2021) Atrial fibrillation in patients with cardiomyopathy: prevalence and clinical outcomes from real-world data. J Am Heart Assoc 10(23):e021970

Article  PubMed  PubMed Central  Google Scholar 

Newhouse JP, McClellan M (1998) Econometrics in outcomes research: the use of instrumental variables. Annu Rev Public Health 19:17–34

Article  CAS  PubMed  Google Scholar 

Gill D, Cameron AC, Burgess S, Li X, Doherty DJ, Karhunen V, Abdul-Rahim AH, Taylor-Rowan M, Zuber V, Tsao PS et al (2021) Urate, blood pressure, and cardiovascular disease: evidence from mendelian randomization and meta-analysis of clinical trials. Hypertension 77(2):383–392

Article  CAS  PubMed  Google Scholar 

Skrivankova VW, Richmond RC, Woolf BAR, Davies NM, Swanson SA, VanderWeele TJ, Timpson NJ, Higgins JPT, Dimou N, Langenberg C et al (2021) Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ 375:n2233

Article  PubMed  PubMed Central  Google Scholar 

Sakaue S, Kanai M, Tanigawa Y, Karjalainen J, Kurki M, Koshiba S, Narita A, Konuma T, Yamamoto K, Akiyama M et al (2021) A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet 53(10):1415–1424

Article  CAS  PubMed  Google Scholar 

Kurki MI, Karjalainen J, Palta P, Sipila TP, Kristiansson K, Donner KM, Reeve MP, Laivuori H, Aavikko M, Kaunisto MA et al (2023) FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613(7944):508–518

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, Downey P, Elliott P, Green J, Landray M et al (2015) UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 12(3):e1001779

Article  PubMed  PubMed Central  Google Scholar 

Burgess S, Butterworth A, Thompson SG (2013) Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 37(7):658–665

Article  PubMed  PubMed Central  Google Scholar 

Zou XL, Wang S, Wang LY, Xiao LX, Yao TX, Zeng Y, Zhang L (2021) Childhood obesity and risk of stroke: a mendelian randomisation analysis. Front Genet 12:727475

Article  PubMed  PubMed Central  Google Scholar 

Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan NA, Thompson JR (2016) Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int J Epidemiol 45(6):1961–1974

PubMed  PubMed Central  Google Scholar 

Burgess S, Thompson SG, Collaboration CCG (2011) Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol 40(3):755–764

Article  PubMed  Google Scholar 

Rees JMB, Wood AM, Burgess S (2017) Extending the MR-Egger method for multivariable Mendelian randomization to correct for both measured and unmeasured pleiotropy. Stat Med 36(29):4705–4718

Article  PubMed  PubMed Central  Google Scholar 

Verbanck M, Chen CY, Neale B, Do R (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 50(5):693–698

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carter AR, Sanderson E, Hammerton G, Richmond RC, Davey Smith G, Heron J, Taylor AE, Davies NM, Howe LD (2021) Mendelian randomisation for mediation analysis: current methods and challenges for implementation. Eur J Epidemiol 36(5):465–478

Article  PubMed  PubMed Central  Google Scholar 

Patten M, Pecha S, Aydin A (2018) Atrial fibrillation in hypertrophic cardiomyopathy: diagnosis and considerations for management. J Atr Fibril 10(5):1556

Article  Google Scholar 

MacIntyre C, Lakdawala NK (2016) Management of atrial fibrillation in hypertrophic cardiomyopathy. Circulation 133(19):1901–1905

Article  PubMed  Google Scholar 

Latif A, Ahmad S, Ahsan MJ, Willman C, Lateef N, Kapoor V, Ikram S, Ahsan MZ, Meyers J, Kim MH (2023) Catheter ablation of atrial fibrillation in hypertrophic cardiomyopathy: a proportional meta-analysis and systematic review of single-arm studies. Heart Rhythm O2 4(4):258–267

Article  PubMed  PubMed Central  Google Scholar 

Winters J, Isaacs A, Zeemering S, Kawczynski M, Maesen B, Maessen J, Bidar E, Boukens B, Hermans B, van Hunnik A et al (2023) Heart failure, female sex, and atrial fibrillation are the main drivers of human atrial cardiomyopathy: results from the CATCH ME consortium. J Am Heart Assoc 12(22):e031220

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zou F, Levine H, Mohanty S, Natale A, Di Biase L (2025) Atrial fibrillation-induced cardiomyopathy. Card Electrophysiol Clin 17(1):13–18

Article  PubMed  Google Scholar 

Alahwany S, Richardson TD, Tandri H (2024) Atrial fibrillation-induced cardiomyopathy: rhythm is gonna get you. JACC Clin Electrophysiol 10(5):882–884

Article  PubMed  Google Scholar 

Sossalla S, Vollmann D (2018) Arrhythmia-induced cardiomyopathy. Dtsch Arztebl Int 115(19):335–341

PubMed  PubMed Central  Google Scholar 

Seferovic PM, Polovina M, Bauersachs J, Arad M, Ben Gal T, Lund LH, Felix SB, Arbustini E, Caforio ALP, Farmakis D et al (2019) Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 21(5):553–576

Article  PubMed  Google Scholar 

Brownrigg JR, Leo V, Rose J, Low E, Richards S, Carr-White G, Elliott PM (2022) Epidemiology of cardiomyopathies and incident heart failure in a population-based cohort study. Heart 108(17):1383–1391